Atossa Genetics Hires Cindy Atha as Vice President of Sales

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Atossa Genetics Hires Cindy Atha as Vice President of Sales and Marketing

SEATTLE, WA--(Marketwired - May 5, 2015) - Atossa Genetics Inc. ( NASDAQ : ATOS ) today announced that Cindy Atha has joined the Company as Vice President of Sales and Marketing, effective May 4, 2015. 

Steven C. Quay, M.D., Ph.D., President and CEO, commented, "Ms. Atha is a highly experienced sales and marketing executive with leadership history in a series of increasingly responsible commercial management roles at Depomed, Inc. and Amylin Pharmaceuticals, both innovative biopharmaceutical companies, as well as AstraZeneca, one of the world's leading pharmaceutical companies. We look forward to Ms. Atha's contributions as we commercialize our medical devices and laboratory services, and as we develop pharmaceutical treatments for breast health conditions."

Prior to joining Atossa, Ms. Atha was Vice President of Managed Markets for Depomed, leading a team that focused on third party reimbursement, pricing, and distribution management. While Vice President of Managed Markets and Trade at Amylin Pharmaceuticals, her team was twice recognized for "Best Marketing Programs and People" for a small manufacturer, and also achieved the 2012 DIANA Award for best new product introduction. Ms. Atha began her 24 years of pharmaceutical experience in field sales with Merck & Co. and then moved to AstraZeneca where she advanced into senior sales leadership. She has received more than 16 sales awards for exceptional individual and group performance including AstraZeneca's prestigious "Leadership Excellence Award." Ms. Atha helped bring over 15 new pharmaceutical products to market and she gained formative experience as an account executive with scientific technologies, promoting the sale of research and medical equipment to leading biotechnology companies and medical centers. She also serves on the Board of Directors for Operation of Hope, a non-profit organization that provides facial reconstructive surgeries to poor children around the world. Ms. Atha received her Bachelor of Science in Zoology from North Carolina State University in Raleigh, North Carolina.

On May 4, 2015, and as an inducement to cause Ms. Atha to join the Company, she was awarded an option to purchase a total of 200,000 shares of common stock of the Company, par value $0.001 per share, which are outside the Company's 2010 Stock Option and Incentive Plan but are subject to the terms of that plan. The stock option has an exercise price equal to $1.44 per share, the fair market value on the grant date and vests 25% at the end of the first year of employment and quarterly after that over the following three years of service. This stock option was granted as an inducement material to Ms. Atha entering into employment with the Company and is being reported in accordance with NASDAQ Listing Rule 5635(c)(4).

About Atossa Genetics

Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics. The laboratory services are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The laboratory services and the Company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For more information, please visit www.atossagenetics.com .

Forward-Looking Statements

Forward-looking statements in this press release are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions by the FDA, the outcome or timing of regulatory approvals needed by Atossa to sell its products, responses to regulatory matters, Atossa's ability to achieve its objectives and continue to manufacture and sell its products, recalls of products, the safety and efficacy of Atossa's products and services, performance of distributors, whether Atossa can launch and commercialize in the United States and foreign markets the additional tests, devices and therapeutics in its pipeline in a timely and cost effective manner, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time. Atossa does not undertake any obligation to update any forward looking statement.

Contact: Atossa Genetics Inc.: Steven C. Quay, M.D., Ph.D. Chief Executive Officer and President (O) 800-351-3902 Kyle Guse CFO and General Counsel (O) 800-351-3902 Investor Relations: CorProminence LLC Scott Gordon President 516-222-2560 scottg@corprominence.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 165

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Teachers in Space Takes Its Classroom Model Orbital

Updated Category News Views 107

Two teachers strapped into a research flight may sound like a glossy space-age photo op, but the useful part of this plan sits back in the classroom with the students staring at the data. Teachers in Space wants to send two educators aboard a Virgin Galactic research flight expected in 2027, and it is raising $2 million to fund the broader educational program and mission....

Continue Reading
Hagerty's Fifth Film Win Keeps Its Media Engine Humming

Updated Category News Views 67

A lap record, a camera crew, and five straight trophies make a louder statement than another glossy corporate slogan. Hagerty won Best Journalism Film at the 2026 International Motor Film Awards on Nov. 14, held at the Petersen Automotive Museum in Los Angeles. The company has taken that particular award home five years running, powered again by Jason Cammisa and his...

Continue Reading
Jumia’s Breakeven Retreat Invites Legal Scrutiny

Updated Category News Views 108

Jumia’s credibility problem did not arrive wearing a disguise. The company spent much of 2026 telling investors that a fourth-quarter Adjusted EBITDA breakeven was still on the table, then discarded that target after reporting third-quarter results. For holders of NYSE:JMIA, that kind of reversal stings because the promise was not some stray talking point; it was...

Continue Reading
Marina del Rey's Travel Award Brings Fresh Attention

Updated Category News Views 78

A harbor town just got handed a useful little megaphone. On November 18, 2026, the Marina del Rey Tourism Board said Marina del Rey had been selected as a winner in Good Housekeeping's 2027 Travel Awards. That is not a quarterly earnings event, and nobody ought to dress it up as one. Still, in the visitor economy, recognition from a broad consumer publication can matter...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 124

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Norfolk Southern's 200-Year Campaign Meets a Hard Market

Updated Category News Views 61

Two centuries of railroad history can stir the blood, but it does not move a single carload by itself. Norfolk Southern has opened its 200-year railroading celebration with the GeneratioNS campaign, a three-locomotive NS 200 commemorative series, and plans for public events across its network. For a railroad with deep roots and very modern operational pressures, this is...

Continue Reading
Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 118

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
Lithium's Next Leg Depends on Storage, Not EV Hype

Updated Category News Views 93

Grid batteries are quietly becoming lithium’s second engine, and that matters more than another flashy electric-vehicle sales headline. The market is projected to rise from $40.87 billion in 2026 to $57.77 billion by 2031, a 7.2% compound annual growth rate. Respectable growth, certainly. But this is not a straight line, and anybody treating a five-year market forecast...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 123

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading

Top 5 Most Recently Viewed Articles

City National Rochdale Welcomes New Leadership with CEO Appointment

Updated Category News Views 270

New Leadership at City National Rochdale City National Rochdale, LLC is thrilled to announce the promotion of Gregg Giaquinto to the position of Chief Executive Officer. With over 25 years of experience in the financial services sector, Giaquinto is poised to lead the firm into its next chapter. Experience and Strategic Vision Giaquinto's journey with City National...

Continue Reading
Tesla's EV Deliveries Struggle Against Growing Competition

Updated Category News Views 119

Tesla's Challenges in EV Deliveries Tesla (NASDAQ: TSLA) delivered approximately 1.64 million electric vehicles in a recent year, falling behind competitors like BYD, which surpassed 2.2 million deliveries. This represents a second consecutive annual decline for Tesla, signifying growing challenges within its automotive sector. The significant drop in deliveries during...

Continue Reading
Greenwave Technology Solutions Boosts Rare-Earth Recycling Efforts

Updated Category News Views 208

Greenwave Technology Solutions Expands Rare-Earth Metal Recovery In light of recent supply chain challenges, Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) is intensifying its initiatives to recover rare-earth metals from end-of-life products. With key minerals being restricted from export, such as gallium and germanium, the company's moves come at a crucial time,...

Continue Reading
Eyenovia Explores Strategic Opportunities with Chardan's Help

Updated Category News Views 267

Eyenovia Engages Chardan for Strategic Alternatives Review Recently, Eyenovia, Inc. (NASDAQ: EYEN), an innovative ophthalmic technology company, outlined its plans to evaluate various strategic opportunities. By partnering with Chardan, the company will assess a broad spectrum of options aimed at optimizing its business operations and future growth prospects. Advancements...

Continue Reading
Pandion Optimization Alliance: A Legacy of 100 Years Empowering Collaboration

Updated Category News Views 291

Pandion Optimization Alliance Celebrates 100 Years of Success This month marks a momentous occasion for Pandion Optimization Alliance as it celebrates a century of uniting organizations through collaboration and shared strength. What initiated as a small rural hospital project in 1925 has now transformed into a massive multi-billion-dollar marketplace. The vision of the...

Continue Reading